Sort:
Open Access Research Article Issue
Exosome-mimetic vesicles derived from fibroblasts carrying matrine for wound healing
Burns & Trauma 2024, 12: tkae015
Published: 10 October 2026
Abstract PDF (2.4 MB) Collect
Downloads:0
Background

Chronic skin wounds are a leading cause of hospital admissions and reduced life expectancy among older people and individuals with diabetes. Delayed wound healing is often attributed to a series of cellular abnormalities. Matrine, a well-studied component found in Sophora flavescens, is recognized for its anti-inflammatory effects. However, its impact on wound healing still remains uncertain. This study aims to explore the potential of matrine in promoting wound healing.

Methods

In this study, we utilized gradient extrusion to produce fibroblast-derived exosome-mimetic vesicles as carriers for matrine (MHEM). MHEM were characterized using transmission electron microscopy and dynamic light scattering analysis. The therapeutic effect of MHEM in wound healing was explored in vitro and in vivo.

Results

Both matrine and MHEM enhanced the cellular activity as well as the migration of fibroblasts and keratinocytes. The potent anti-inflammatory effect of matrine diluted the inflammatory response in the vicinity of wounds. Furthermore, MHEM worked together to promote angiogenesis and the expression of transforming growth factor β and collagen I. MHEM contained growth factors of fibroblasts that regulated the functions of fibroblasts, keratinocytes and monocytes, which synergistically promoted wound healing with the anti-inflammatory effect of matrine.

Conclusions

MHEM showed enhanced therapeutic efficacy in the inflammatory microenvironment, for new tissue formation and angiogenesis of wound healing.

Open Access Research Article Issue
Stem cell-derived biomimetic apoptotic vesicles enhance macrophage efferocytosis via C1qbp to accelerate diabetic wound healing
Nano Research 2026, 19(7): 94908650
Published: 04 June 2026
Abstract PDF (25.2 MB) Collect
Downloads:220

Chronic diabetic wounds represent a significant therapeutic challenge, characterized by persistent inflammation, impaired angiogenesis, and defective efferocytosis. In this study, we demonstrate that stem cell-derived biomimetic apoptotic vesicles (AVs) are enriched with complement C1q-binding protein (C1qbp), and confirm that C1qbp is a key regulator for macrophage phagocytosis. These AVs potently enhanced macrophage efferocytic activity, promoted polarization from the pro-inflammatory M1 to the anti-inflammatory M2 phenotype, and reduced secretion of the pro-inflammatory cytokines interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α). Moreover, AVs stimulated angiogenesis and cell migration, thereby initiating a coordinated immune-mediated tissue regenerative program. Delivery of AVs via a GelMA hydrogel (AVs@GelMA) markedly accelerated wound healing in diabetic mice by inhibiting nuclear factor-κB (NF-κB)-driven inflammatory signaling and promoting vascularization and tissue remodeling. Collectively, our findings elucidate a three-phase mechanism of "efferocytosis-immunity-regeneration" and highlight C1qbp-enriched AVs as a promising precision therapeutic strategy for chronic diabetic wounds.

Total 2